Abstract
The respiratory system serves as an important interface for gas exchange. It is vital to maintain the health of the airways to ensure a free flow of gases. Certain diseases that affect the airways and the gas exchange site are best treated with drugs delivered directly to the target sites via the inhalational route. This will not only result in immediate action but will keep the required drug dosages to the minimum and thus reduce their systemic side-effects. The non-inhalational mode is an alternative option when the passage to the gas exchange interface is too severely obstructed or if the drugs can only be given via the systemic route. There are two major classes of bronchodilators delivered via the inhalational mode in acute care, i.e., the beta 2 agonists and the anticholinergics. The two differ in both the onset of action as well as the duration of action. A combination of drugs from different classes is often employed in the acute situation to achieve the best bronchodilatory effect. Drug delivery for patients with poor inhalational technique can be assisted by means of a spacer or a nebulizer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Barnes PJ. New therapies of COPD. Thorax. 1998;53:137–47.
Barnes PJ. Theophylline. Am J Respir Crit Care Med. 2003;167(6):813–8.
Barnes PJ. New drugs for asthma. Nat Rev Drug Discov. 2004;3:831–44.
Dockhorn RJ, Baumgartner RA, Leff JA, Noonand M, Vandormaela K, Strickere W. Comparison of the effects of intravenous and oral Montelukast on airway function: a double-blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax. 2000;55:260–5.
Ferguson GT. Update on pharmacologic therapy for chronic obstructive pulmonary disease. Clin Chest Med. 2000;21:723–38.
Jonsson S, Kjartansson G, Gislason D, Helgason H. Comparison of the oral and intravenous routes for treating asthma with methylprednisolone and theophylline. Chest. 1988;94:723–6.
Poole PJ, Black PN. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ. 2001;322:1271–4.
Ratto D, Alfaro C, Sipsey J, Glovsky MM, Sharma OP. Are intravenous corticosteroids required in status asthmaticus? JAMA. 1988;260(4):527–9.
Rodrigo G, Rodrigo C, Burschtin O. Efficacy of magnesium sulfate in acute adult asthma: a meta-analysis of randomized trials. Am J Emerg Med. 2000;18:216–21.
Rolla G, Bucca C, Caria E, Arossa W, Bugiani M, Cesano L, Caropreso A. Acute effect of intravenous magnesium sulfate on airway obstruction of asthmatic patients. Ann Allergy. 1988;61:388–91.
Rowe BH, Bretzlaff J, Bourdon C, Bota G, Blitz S, Camargo CA. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database of Systematic Reviews 2000, Issue 1. Art. No.: CD001490. DOI: 10.1002/14651858.CD001490
Rubin BK, Ramirez O, Ohar JA. Iodinated glycerol has no effect on pulmonary function, symptom score, or sputum properties in patients with stable chronic bronchitis. Chest. 1996;109:348–52.
Silverman RA, Osborn H, Runge J, Gallagher EJ, Chiang W, Feldman J, et al. IV magnesium sulfate in the treatment of acute severe asthma: a multicenter randomized controlled trial. Chest. 2002;122(2):489–97.
van der Velden VH. Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma. Mediators Inflamm. 1998;7(4):229–37.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Pang, YK. (2015). Drugs and the Respiratory System. In: Chan, Y., Ng, K., Sim, D. (eds) Pharmacological Basis of Acute Care. Springer, Cham. https://doi.org/10.1007/978-3-319-10386-0_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-10386-0_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-10385-3
Online ISBN: 978-3-319-10386-0
eBook Packages: MedicineMedicine (R0)